Evolent Health, Inc. financial data

Symbol
EVH on NYSE
Location
1812 North Moore St, Suite 1705, Arlington, VA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98.3 % -5.29%
Debt-to-equity 127 % +1.32%
Return On Assets -2.42 % +43.3%
Operating Margin -3.63 % -1448%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 117M shares
Entity Public Float 2.2B USD -35.3%
Common Stock, Value, Issued 1.17M USD +1.04%
Weighted Average Number of Shares Outstanding, Basic 115M shares +3.08%
Weighted Average Number of Shares Outstanding, Diluted 115M shares +3.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.96B USD +45.3%
Revenue from Contract with Customer, Excluding Assessed Tax 2.55B USD +30.1%
Cost of Revenue 2.19B USD +45.5%
Costs and Expenses 2.6B USD +27.5%
Operating Income (Loss) -40.5M USD +43.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -63M USD +68.9%
Income Tax Expense (Benefit) -1.41M USD +98.4%
Net Income (Loss) Attributable to Parent -61.6M USD +45.5%
Earnings Per Share, Basic -0.82 USD/shares +35.4%
Earnings Per Share, Diluted -0.82 USD/shares +35.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 104M USD -46%
Accounts Receivable, after Allowance for Credit Loss, Current 415M USD -7.18%
Assets, Current 607M USD -11.2%
Property, Plant and Equipment, Net 73.2M USD -6.45%
Operating Lease, Right-of-Use Asset 6.13M USD -48.8%
Intangible Assets, Net (Excluding Goodwill) 680M USD -9.56%
Goodwill 1.14B USD +1.86%
Assets 2.54B USD -5.07%
Accounts Payable, Current 96M USD +99%
Employee-related Liabilities, Current 33.7M USD -40.2%
Accrued Liabilities, Current 66.4M USD -55.7%
Contract with Customer, Liability, Current 2.51M USD -58%
Liabilities, Current 716M USD +6.12%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 10.9M USD -18.1%
Operating Lease, Liability, Noncurrent 25M USD -34.3%
Other Liabilities, Noncurrent 2.98M USD -18%
Liabilities 1.35B USD -5.66%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.75M USD -39.5%
Retained Earnings (Accumulated Deficit) -781M USD -8.57%
Stockholders' Equity Attributable to Parent 1B USD -6.22%
Liabilities and Equity 2.54B USD -5.07%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.91M USD
Net Cash Provided by (Used in) Financing Activities 14.9M USD -96.1%
Net Cash Provided by (Used in) Investing Activities -9.73M USD +97.5%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 117M shares +1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 10M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 178M USD -20.1%
Deferred Tax Assets, Valuation Allowance 47.8M USD +49.5%
Deferred Tax Assets, Gross 194M USD -2.56%
Operating Lease, Liability 51.7M USD +8.25%
Depreciation 30.3M USD -6.48%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -94M USD +34%
Lessee, Operating Lease, Liability, to be Paid 54.2M USD -12%
Property, Plant and Equipment, Gross 253M USD +6.87%
Operating Lease, Liability, Current 26.7M USD +174%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.7M USD +99.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 27.6M USD +120%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +46.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.47M USD -82.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.01M USD -64.9%
Deferred Tax Assets, Operating Loss Carryforwards 125M USD +1.71%
Unrecognized Tax Benefits 2.55M USD -2.04%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.79M USD -77.9%
Operating Lease, Payments 3.53M USD -7.89%
Additional Paid in Capital 1.8B USD -0.24%
Amortization of Intangible Assets 88.1M USD -3.19%
Depreciation, Depletion and Amortization 29.5M USD +0.78%
Deferred Tax Assets, Net of Valuation Allowance 146M USD -12.6%
Share-based Payment Arrangement, Expense 39.7M USD -1.86%
Interest Expense 47.3M USD +80.4%